Investments (#)
Investments (USD)
Transactions
Recent transactions in the domain of cancer treatment
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | Series C USD 95,000,000 (USD 95,000,000) |
13 May 2024 |
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series B USD 21,000,000 (USD 21,000,000) |
7 Jan 2015 |
|
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series A |
6 Jan 2012 |
Companies
Best funded companies in cancer treatment
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.
Investors
Top investors in the domain of cancer treatment
| Investor | Profile | Country | Investments | |
|---|---|---|---|---|
|
Point72 Capital Management LLC | 1 | ||
|
New Enterprise Associates Inc | Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. | United States | 1 |
|
Boxer Capital LLC | Biotech investment firm. | 1 | |
|
|
Eminent Venture Capital | 1 | ||
|
|
Inning One Ventures | 1 | ||
|
Eli Lilly & Co | 1 | ||
|
RA Capital Management | 1 | ||
|
EcoR1 Capital | Biotech-focused investment firm. | 1 | |
|
NanoDimension Management Ltd | Cayman Islands | 1 | |
|
Schrödinger Inc | United States | 1 | |
|
Goldman Sachs Alternative Investments | 1 | ||
|
Vivo Capital LLC | 1 |